fda approves first oral glp-1 obesity drug august 1 2025 pill version of drugs Wegovy Pill Wins FDA Approval
Description
doi: 10.1210/endo-54-3-303
Front Endocrinol (Lausanne) 9
ABSTRACT Obesity is a significant risk factor for health issues like type 2 diabetes and cardiovascular disease
488,489,490 In the pancreas, this stimulates the secretion of insulin and inhibits the secretion of glucagon
200,201,202 Simultaneously, Akt promotes cell survival by phosphorylating and inhibiting a series of pro-apoptotic proteins, such as Bad and the FOXO family
Kunal Shah, an assistant professor in the division of endocrinology at the Rutgers Robert Wood Johnson Medical Center in New Brunswick, New Jersey
